nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—DRD2—nicotine dependence	0.668	1	CbGaD
Bromocriptine—Pleurisy—Varenicline—nicotine dependence	0.012	0.0937	CcSEcCtD
Bromocriptine—Libido increased—Varenicline—nicotine dependence	0.00483	0.0376	CcSEcCtD
Bromocriptine—Paranoia—Varenicline—nicotine dependence	0.00431	0.0336	CcSEcCtD
Bromocriptine—Delusion—Varenicline—nicotine dependence	0.00415	0.0323	CcSEcCtD
Bromocriptine—Mania—Varenicline—nicotine dependence	0.00404	0.0315	CcSEcCtD
Bromocriptine—Ergoloid mesylate—DRD2—nicotine dependence	0.00382	0.719	CrCbGaD
Bromocriptine—Rhinorrhoea—Varenicline—nicotine dependence	0.00362	0.0282	CcSEcCtD
Bromocriptine—Nightmare—Varenicline—nicotine dependence	0.00284	0.0221	CcSEcCtD
Bromocriptine—Diabetes mellitus—Varenicline—nicotine dependence	0.00245	0.0191	CcSEcCtD
Bromocriptine—Visual disturbance—Varenicline—nicotine dependence	0.00225	0.0175	CcSEcCtD
Bromocriptine—DRD4—brain—nicotine dependence	0.00222	0.0501	CbGeAlD
Bromocriptine—Hypoglycaemia—Varenicline—nicotine dependence	0.00218	0.017	CcSEcCtD
Bromocriptine—Lethargy—Varenicline—nicotine dependence	0.00218	0.0169	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Varenicline—nicotine dependence	0.00218	0.0169	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00213	0.0166	CcSEcCtD
Bromocriptine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00211	0.0165	CcSEcCtD
Bromocriptine—Psychotic disorder—Varenicline—nicotine dependence	0.00208	0.0162	CcSEcCtD
Bromocriptine—Urinary retention—Varenicline—nicotine dependence	0.00203	0.0158	CcSEcCtD
Bromocriptine—Abdominal pain upper—Varenicline—nicotine dependence	0.00195	0.0152	CcSEcCtD
Bromocriptine—Cramp muscle—Varenicline—nicotine dependence	0.00192	0.015	CcSEcCtD
Bromocriptine—Nasopharyngitis—Varenicline—nicotine dependence	0.00191	0.0149	CcSEcCtD
Bromocriptine—HTR1B—cardiovascular system—nicotine dependence	0.00185	0.0417	CbGeAlD
Bromocriptine—Dysphagia—Varenicline—nicotine dependence	0.00184	0.0144	CcSEcCtD
Bromocriptine—HTR1D—cardiovascular system—nicotine dependence	0.00179	0.0403	CbGeAlD
Bromocriptine—DRD1—midbrain—nicotine dependence	0.00178	0.0402	CbGeAlD
Bromocriptine—Abdominal discomfort—Varenicline—nicotine dependence	0.00177	0.0138	CcSEcCtD
Bromocriptine—ADRB1—cardiovascular system—nicotine dependence	0.00174	0.0392	CbGeAlD
Bromocriptine—Pollakiuria—Varenicline—nicotine dependence	0.0017	0.0133	CcSEcCtD
Bromocriptine—HTR2B—cardiovascular system—nicotine dependence	0.00166	0.0375	CbGeAlD
Bromocriptine—Acute coronary syndrome—Varenicline—nicotine dependence	0.00162	0.0126	CcSEcCtD
Bromocriptine—Myocardial infarction—Varenicline—nicotine dependence	0.00161	0.0125	CcSEcCtD
Bromocriptine—DRD3—brain—nicotine dependence	0.00156	0.0352	CbGeAlD
Bromocriptine—Sinusitis—Varenicline—nicotine dependence	0.00154	0.012	CcSEcCtD
Bromocriptine—HTR6—brain—nicotine dependence	0.0015	0.0339	CbGeAlD
Bromocriptine—Bradycardia—Varenicline—nicotine dependence	0.0015	0.0117	CcSEcCtD
Bromocriptine—HTR1A—cardiovascular system—nicotine dependence	0.00149	0.0336	CbGeAlD
Bromocriptine—Ergotamine—DRD2—nicotine dependence	0.00149	0.281	CrCbGaD
Bromocriptine—Hypoaesthesia—Varenicline—nicotine dependence	0.00147	0.0114	CcSEcCtD
Bromocriptine—Hallucination—Varenicline—nicotine dependence	0.00147	0.0114	CcSEcCtD
Bromocriptine—DRD5—brain—nicotine dependence	0.00146	0.033	CbGeAlD
Bromocriptine—Oedema peripheral—Varenicline—nicotine dependence	0.00145	0.0113	CcSEcCtD
Bromocriptine—Connective tissue disorder—Varenicline—nicotine dependence	0.00145	0.0113	CcSEcCtD
Bromocriptine—HTR1B—midbrain—nicotine dependence	0.00144	0.0325	CbGeAlD
Bromocriptine—HTR7—cardiovascular system—nicotine dependence	0.00143	0.0321	CbGeAlD
Bromocriptine—Visual impairment—Varenicline—nicotine dependence	0.00142	0.0111	CcSEcCtD
Bromocriptine—HTR1D—midbrain—nicotine dependence	0.0014	0.0315	CbGeAlD
Bromocriptine—HTR2C—midbrain—nicotine dependence	0.00138	0.0312	CbGeAlD
Bromocriptine—Eye disorder—Varenicline—nicotine dependence	0.00138	0.0107	CcSEcCtD
Bromocriptine—Tinnitus—Varenicline—nicotine dependence	0.00137	0.0107	CcSEcCtD
Bromocriptine—ADRA1A—cardiovascular system—nicotine dependence	0.00137	0.031	CbGeAlD
Bromocriptine—Cardiac disorder—Varenicline—nicotine dependence	0.00137	0.0107	CcSEcCtD
Bromocriptine—Angiopathy—Varenicline—nicotine dependence	0.00134	0.0104	CcSEcCtD
Bromocriptine—Mediastinal disorder—Varenicline—nicotine dependence	0.00133	0.0104	CcSEcCtD
Bromocriptine—Arrhythmia—Varenicline—nicotine dependence	0.00132	0.0103	CcSEcCtD
Bromocriptine—Mental disorder—Varenicline—nicotine dependence	0.00129	0.0101	CcSEcCtD
Bromocriptine—Dysgeusia—Varenicline—nicotine dependence	0.00126	0.0098	CcSEcCtD
Bromocriptine—Muscle spasms—Varenicline—nicotine dependence	0.00123	0.00962	CcSEcCtD
Bromocriptine—Vision blurred—Varenicline—nicotine dependence	0.00121	0.00943	CcSEcCtD
Bromocriptine—ADRA1B—brain—nicotine dependence	0.0012	0.0271	CbGeAlD
Bromocriptine—Agitation—Varenicline—nicotine dependence	0.00118	0.00919	CcSEcCtD
Bromocriptine—ADRA1D—brain—nicotine dependence	0.00117	0.0265	CbGeAlD
Bromocriptine—HTR1A—midbrain—nicotine dependence	0.00116	0.0263	CbGeAlD
Bromocriptine—Vertigo—Varenicline—nicotine dependence	0.00115	0.00899	CcSEcCtD
Bromocriptine—Syncope—Varenicline—nicotine dependence	0.00115	0.00897	CcSEcCtD
Bromocriptine—Loss of consciousness—Varenicline—nicotine dependence	0.00113	0.00879	CcSEcCtD
Bromocriptine—DRD1—brain—nicotine dependence	0.00112	0.0252	CbGeAlD
Bromocriptine—HTR7—midbrain—nicotine dependence	0.00111	0.0251	CbGeAlD
Bromocriptine—Convulsion—Varenicline—nicotine dependence	0.00111	0.00867	CcSEcCtD
Bromocriptine—Hypertension—Varenicline—nicotine dependence	0.00111	0.00864	CcSEcCtD
Bromocriptine—Anxiety—Varenicline—nicotine dependence	0.00109	0.00849	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00109	0.00846	CcSEcCtD
Bromocriptine—Dry mouth—Varenicline—nicotine dependence	0.00107	0.00833	CcSEcCtD
Bromocriptine—DRD2—midbrain—nicotine dependence	0.00105	0.0237	CbGeAlD
Bromocriptine—Oedema—Varenicline—nicotine dependence	0.00105	0.00816	CcSEcCtD
Bromocriptine—Infection—Varenicline—nicotine dependence	0.00104	0.00811	CcSEcCtD
Bromocriptine—Shock—Varenicline—nicotine dependence	0.00103	0.00803	CcSEcCtD
Bromocriptine—Nervous system disorder—Varenicline—nicotine dependence	0.00103	0.00801	CcSEcCtD
Bromocriptine—ADRA2C—midbrain—nicotine dependence	0.00102	0.0231	CbGeAlD
Bromocriptine—Tachycardia—Varenicline—nicotine dependence	0.00102	0.00797	CcSEcCtD
Bromocriptine—Skin disorder—Varenicline—nicotine dependence	0.00102	0.00793	CcSEcCtD
Bromocriptine—Anorexia—Varenicline—nicotine dependence	0.000999	0.00778	CcSEcCtD
Bromocriptine—Hypotension—Varenicline—nicotine dependence	0.000979	0.00763	CcSEcCtD
Bromocriptine—Insomnia—Varenicline—nicotine dependence	0.000948	0.00738	CcSEcCtD
Bromocriptine—Dyspnoea—Varenicline—nicotine dependence	0.000934	0.00728	CcSEcCtD
Bromocriptine—Somnolence—Varenicline—nicotine dependence	0.000931	0.00726	CcSEcCtD
Bromocriptine—Dyspepsia—Varenicline—nicotine dependence	0.000922	0.00719	CcSEcCtD
Bromocriptine—Decreased appetite—Varenicline—nicotine dependence	0.000911	0.0071	CcSEcCtD
Bromocriptine—HTR1B—brain—nicotine dependence	0.000907	0.0205	CbGeAlD
Bromocriptine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000905	0.00705	CcSEcCtD
Bromocriptine—Fatigue—Varenicline—nicotine dependence	0.000903	0.00704	CcSEcCtD
Bromocriptine—Constipation—Varenicline—nicotine dependence	0.000896	0.00698	CcSEcCtD
Bromocriptine—HTR2A—cardiovascular system—nicotine dependence	0.000889	0.02	CbGeAlD
Bromocriptine—HTR1D—brain—nicotine dependence	0.000878	0.0198	CbGeAlD
Bromocriptine—HTR2C—brain—nicotine dependence	0.000869	0.0196	CbGeAlD
Bromocriptine—Feeling abnormal—Varenicline—nicotine dependence	0.000863	0.00673	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Varenicline—nicotine dependence	0.000857	0.00668	CcSEcCtD
Bromocriptine—ADRB1—brain—nicotine dependence	0.000853	0.0192	CbGeAlD
Bromocriptine—Urticaria—Varenicline—nicotine dependence	0.000832	0.00649	CcSEcCtD
Bromocriptine—Abdominal pain—Varenicline—nicotine dependence	0.000828	0.00645	CcSEcCtD
Bromocriptine—Body temperature increased—Varenicline—nicotine dependence	0.000828	0.00645	CcSEcCtD
Bromocriptine—HTR2B—brain—nicotine dependence	0.000817	0.0184	CbGeAlD
Bromocriptine—ADRA2A—midbrain—nicotine dependence	0.000816	0.0184	CbGeAlD
Bromocriptine—Asthenia—Varenicline—nicotine dependence	0.000752	0.00586	CcSEcCtD
Bromocriptine—HTR1A—brain—nicotine dependence	0.000732	0.0165	CbGeAlD
Bromocriptine—Diarrhoea—Varenicline—nicotine dependence	0.000717	0.00559	CcSEcCtD
Bromocriptine—HTR7—brain—nicotine dependence	0.000699	0.0158	CbGeAlD
Bromocriptine—HTR2A—midbrain—nicotine dependence	0.000694	0.0157	CbGeAlD
Bromocriptine—Dizziness—Varenicline—nicotine dependence	0.000693	0.0054	CcSEcCtD
Bromocriptine—ADRA1A—brain—nicotine dependence	0.000675	0.0152	CbGeAlD
Bromocriptine—Vomiting—Varenicline—nicotine dependence	0.000666	0.00519	CcSEcCtD
Bromocriptine—DRD2—brain—nicotine dependence	0.000661	0.0149	CbGeAlD
Bromocriptine—Rash—Varenicline—nicotine dependence	0.000661	0.00515	CcSEcCtD
Bromocriptine—Dermatitis—Varenicline—nicotine dependence	0.00066	0.00514	CcSEcCtD
Bromocriptine—Headache—Varenicline—nicotine dependence	0.000656	0.00511	CcSEcCtD
Bromocriptine—ADRA2C—brain—nicotine dependence	0.000643	0.0145	CbGeAlD
Bromocriptine—Nausea—Varenicline—nicotine dependence	0.000622	0.00485	CcSEcCtD
Bromocriptine—ABCB1—cardiovascular system—nicotine dependence	0.000582	0.0131	CbGeAlD
Bromocriptine—ADRA2A—brain—nicotine dependence	0.000513	0.0116	CbGeAlD
Bromocriptine—ABCB1—midbrain—nicotine dependence	0.000455	0.0103	CbGeAlD
Bromocriptine—HTR2A—brain—nicotine dependence	0.000436	0.00984	CbGeAlD
Bromocriptine—ABCB1—brain—nicotine dependence	0.000286	0.00644	CbGeAlD
Bromocriptine—DRD4—GPCR ligand binding—DRD2—nicotine dependence	0.000118	0.000769	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TAS2R16—nicotine dependence	0.000118	0.000765	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000117	0.000761	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000117	0.00076	CbGpPWpGaD
Bromocriptine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000116	0.000756	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000115	0.000749	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000115	0.000748	CbGpPWpGaD
Bromocriptine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000114	0.000744	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—OPRM1—nicotine dependence	0.000114	0.000739	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000113	0.000734	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000113	0.000732	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000112	0.00073	CbGpPWpGaD
Bromocriptine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000111	0.000723	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—AKR1B10—nicotine dependence	0.00011	0.000718	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00011	0.000717	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000109	0.000711	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000107	0.000696	CbGpPWpGaD
Bromocriptine—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000106	0.000692	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000106	0.00069	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000106	0.000688	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.000105	0.000683	CbGpPWpGaD
Bromocriptine—DRD3—GPCR ligand binding—DRD2—nicotine dependence	0.000105	0.000683	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000105	0.00068	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000104	0.000679	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000104	0.000679	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	0.000104	0.000679	CbGpPWpGaD
Bromocriptine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000104	0.000675	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000102	0.000665	CbGpPWpGaD
Bromocriptine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000102	0.000661	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	9.94e-05	0.000647	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	9.66e-05	0.000628	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—OPRM1—nicotine dependence	9.65e-05	0.000628	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—FGD1—nicotine dependence	9.64e-05	0.000627	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—FGD1—nicotine dependence	9.63e-05	0.000627	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	9.59e-05	0.000624	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—FGD1—nicotine dependence	9.57e-05	0.000623	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR ligand binding—DRD2—nicotine dependence	9.56e-05	0.000622	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TAS2R16—nicotine dependence	9.51e-05	0.000619	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	9.5e-05	0.000618	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	9.48e-05	0.000616	CbGpPWpGaD
Bromocriptine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.44e-05	0.000614	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	9.42e-05	0.000613	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	9.39e-05	0.000611	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—FGD1—nicotine dependence	9.37e-05	0.00061	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—OPRM1—nicotine dependence	9.24e-05	0.000601	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—FGD1—nicotine dependence	9.22e-05	0.0006	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	9.15e-05	0.000595	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	9.1e-05	0.000592	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	9.1e-05	0.000592	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	9.05e-05	0.000589	CbGpPWpGaD
Bromocriptine—DRD5—GPCR downstream signaling—DRD2—nicotine dependence	9.05e-05	0.000589	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	8.85e-05	0.000576	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	8.82e-05	0.000574	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—FGD1—nicotine dependence	8.8e-05	0.000573	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	8.8e-05	0.000573	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	8.77e-05	0.000571	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—OPRM1—nicotine dependence	8.76e-05	0.00057	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	8.71e-05	0.000567	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	8.7e-05	0.000566	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	8.66e-05	0.000564	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	8.52e-05	0.000554	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	8.52e-05	0.000554	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	8.51e-05	0.000554	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	8.45e-05	0.00055	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	8.39e-05	0.000546	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	8.31e-05	0.000541	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—FGD1—nicotine dependence	8.3e-05	0.00054	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	8.28e-05	0.000539	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—DRD2—nicotine dependence	8.22e-05	0.000534	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	8.2e-05	0.000534	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	8.2e-05	0.000534	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	8.19e-05	0.000533	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—FGD1—nicotine dependence	8.19e-05	0.000533	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	8.15e-05	0.00053	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	8.14e-05	0.000529	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	8.01e-05	0.000521	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	7.99e-05	0.00052	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	7.9e-05	0.000514	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	7.86e-05	0.000511	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	7.78e-05	0.000506	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—WASF2—nicotine dependence	7.78e-05	0.000506	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	7.74e-05	0.000503	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	7.7e-05	0.000501	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	7.55e-05	0.000491	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	7.47e-05	0.000486	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—FGD1—nicotine dependence	7.46e-05	0.000486	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—WASF1—nicotine dependence	7.46e-05	0.000485	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	7.45e-05	0.000485	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	7.45e-05	0.000485	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	7.41e-05	0.000482	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	7.4e-05	0.000481	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	7.33e-05	0.000477	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	7.24e-05	0.000471	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	7.24e-05	0.000471	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	7.19e-05	0.000468	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	7.15e-05	0.000465	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	7.15e-05	0.000465	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	7.14e-05	0.000464	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	7.11e-05	0.000463	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	7.1e-05	0.000462	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	6.98e-05	0.000454	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	6.98e-05	0.000454	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	6.93e-05	0.000451	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.92e-05	0.00045	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	6.91e-05	0.000449	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	6.81e-05	0.000443	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	6.8e-05	0.000442	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	6.79e-05	0.000442	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	6.79e-05	0.000441	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—CYP2A7—nicotine dependence	6.78e-05	0.000441	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	6.73e-05	0.000438	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—OPRM1—nicotine dependence	6.71e-05	0.000437	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	6.68e-05	0.000434	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	6.59e-05	0.000429	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	6.53e-05	0.000425	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	6.49e-05	0.000422	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	6.46e-05	0.00042	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	6.37e-05	0.000415	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—DRD2—nicotine dependence	6.34e-05	0.000413	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—DRD2—nicotine dependence	6.33e-05	0.000412	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	6.31e-05	0.00041	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	6.29e-05	0.000409	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	6.28e-05	0.000409	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	6.28e-05	0.000408	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	6.27e-05	0.000408	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—FGD1—nicotine dependence	6.27e-05	0.000408	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	6.18e-05	0.000402	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	6.18e-05	0.000402	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	6.17e-05	0.000401	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	6.16e-05	0.000401	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	6.1e-05	0.000397	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—DRD2—nicotine dependence	6.06e-05	0.000394	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	6.05e-05	0.000393	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	6.04e-05	0.000393	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	6.01e-05	0.000391	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	6.01e-05	0.000391	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—WASF2—nicotine dependence	6e-05	0.00039	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—WASF2—nicotine dependence	6e-05	0.00039	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—WASF2—nicotine dependence	5.96e-05	0.000388	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	5.93e-05	0.000386	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	5.93e-05	0.000386	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—WASF2—nicotine dependence	5.83e-05	0.000379	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	5.79e-05	0.000377	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—WASF1—nicotine dependence	5.75e-05	0.000374	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—WASF1—nicotine dependence	5.75e-05	0.000374	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—WASF2—nicotine dependence	5.74e-05	0.000373	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—WASF1—nicotine dependence	5.71e-05	0.000372	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	5.7e-05	0.000371	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.62e-05	0.000366	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	5.61e-05	0.000365	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	5.61e-05	0.000365	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—WASF1—nicotine dependence	5.59e-05	0.000364	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	5.54e-05	0.00036	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	5.51e-05	0.000359	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—WASF1—nicotine dependence	5.5e-05	0.000358	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	5.49e-05	0.000357	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—WASF2—nicotine dependence	5.48e-05	0.000356	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—DRD2—nicotine dependence	5.46e-05	0.000355	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	5.45e-05	0.000354	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	5.4e-05	0.000352	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	5.39e-05	0.00035	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—DRD2—nicotine dependence	5.39e-05	0.00035	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	5.35e-05	0.000348	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	5.33e-05	0.000347	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—WASF1—nicotine dependence	5.25e-05	0.000342	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—OPRM1—nicotine dependence	5.18e-05	0.000337	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—OPRM1—nicotine dependence	5.18e-05	0.000337	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	5.17e-05	0.000336	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—WASF2—nicotine dependence	5.17e-05	0.000336	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	5.14e-05	0.000335	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	5.14e-05	0.000335	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	5.1e-05	0.000332	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	5.1e-05	0.000332	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—WASF2—nicotine dependence	5.1e-05	0.000332	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	5.03e-05	0.000328	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	5e-05	0.000325	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	4.96e-05	0.000322	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—OPRM1—nicotine dependence	4.95e-05	0.000322	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—WASF1—nicotine dependence	4.95e-05	0.000322	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	4.92e-05	0.00032	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	4.91e-05	0.000319	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	4.89e-05	0.000318	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—WASF1—nicotine dependence	4.89e-05	0.000318	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	4.86e-05	0.000316	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—DRD2—nicotine dependence	4.85e-05	0.000316	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	4.73e-05	0.000308	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	4.69e-05	0.000305	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.67e-05	0.000304	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—WASF2—nicotine dependence	4.65e-05	0.000302	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	4.6e-05	0.000299	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	4.54e-05	0.000295	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	4.47e-05	0.000291	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	4.47e-05	0.000291	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—OPRM1—nicotine dependence	4.46e-05	0.00029	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—WASF1—nicotine dependence	4.45e-05	0.00029	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	4.44e-05	0.000289	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	4.42e-05	0.000288	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	4.41e-05	0.000287	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	4.4e-05	0.000286	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—OPRM1—nicotine dependence	4.4e-05	0.000286	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	4.37e-05	0.000284	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	4.3e-05	0.00028	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	4.26e-05	0.000277	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	4.24e-05	0.000276	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	4.23e-05	0.000275	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	4.12e-05	0.000268	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	4.06e-05	0.000264	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	4.06e-05	0.000264	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	4.06e-05	0.000264	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	4.01e-05	0.000261	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	3.97e-05	0.000258	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	3.97e-05	0.000258	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.9e-05	0.000254	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	3.84e-05	0.00025	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	3.84e-05	0.00025	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.82e-05	0.000248	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CYP2A7—nicotine dependence	3.81e-05	0.000248	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	3.76e-05	0.000245	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—DRD2—nicotine dependence	3.75e-05	0.000244	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—DRD2—nicotine dependence	3.74e-05	0.000243	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.74e-05	0.000243	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—DRD2—nicotine dependence	3.72e-05	0.000242	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	3.71e-05	0.000241	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	3.69e-05	0.00024	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.68e-05	0.000239	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	3.65e-05	0.000238	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—DRD2—nicotine dependence	3.64e-05	0.000237	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	3.6e-05	0.000234	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—DRD2—nicotine dependence	3.58e-05	0.000233	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	3.49e-05	0.000227	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—DRD2—nicotine dependence	3.42e-05	0.000222	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	3.37e-05	0.000219	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	3.35e-05	0.000218	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	3.31e-05	0.000216	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	3.24e-05	0.000211	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—DRD2—nicotine dependence	3.22e-05	0.00021	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	3.18e-05	0.000207	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—DRD2—nicotine dependence	3.18e-05	0.000207	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	3.04e-05	0.000198	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	3.01e-05	0.000196	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—DRD2—nicotine dependence	2.9e-05	0.000189	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	2.87e-05	0.000187	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.77e-05	0.00018	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.76e-05	0.000179	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	2.68e-05	0.000175	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	2.64e-05	0.000172	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.4e-05	0.000156	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.35e-05	0.000153	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	2.35e-05	0.000153	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	2.18e-05	0.000142	CbGpPWpGaD
